Advertisement
The PLoS Medicine Debate

The PLoS Medicine Debate The PLOS Medicine Debate discusses important but controversial issues in clinical practice, public health policy, or health in general. Debates will be commissioned from two or more authors with differing points of view.

See all article types »

Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Technology?

  • Ross McKinney,
  • David Korn
  • Published: January 25, 2005
  • DOI: 10.1371/journal.pmed.0020009

About the Authors

Competing Interests

RM reports that he is employed by an academic medical center that has both intellectual property and performs clinical trials. DK declares that he has no competing interests.